Nutrien Ltd. NTR recorded a profit of $19 million or 2 cents per share for first-quarter 2025, down from $165 million or 32 cents in the year-ago quarter. Barring one-time items, adjusted earnings per share were 11 cents, down from 46 cents a year ago. The bottom line missed the Zacks Consensus Estimate of 33 cents. Sales fell around 5.4% year over year to $5,100 million in the quarter. The figure lagged the Zacks Consensus Estimate of $5,322.3 million. Net earnings and adjusted EBITDA declined due to lower potash net selling prices in North America, higher phosphate expenses and reduced retail earnings. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Nutrien Ltd. Price, Consensus and EPS Surprise Nutrien Ltd. price-consensus-eps-surprise-chart | Nutrien Ltd. Quote NTR’s Segment Highlights Sales in the Nutrien Ag Solutions (Retail) segment declined 7% year over year to $3,090 million in the quarter. The figure missed our estimate of $4,076.6 million. Retail adjusted EBITDA fell in the reported quarter, owing to lower gross margins for crop protection products and crop nutrients, which more than offset lower expenses and increased seed margins. The Potash division’s sales declined 8% year over year to $744 million, topping our estimate of $501.4 million. Potash adjusted EBITDA fell in the first quarter of 2025 due to reduced net selling prices in North America. Sales in the Nitrogen segment were $954 million, up around 5% year over year. The reported figure beat our estimate of $671.9 million. Nitrogen adjusted EBITDA fell in the first quarter, primarily due to higher natural gas costs and reduced equity earnings, which were somewhat offset by higher net selling prices. Sales in the Phosphate segment were $360 million, down around 18% year over year. The figure topped our estimate of $253.6 million. Phosphate adjusted EBITDA decreased in the first quarter as a result of lower production volumes and higher input costs, notably sulfur. NTR’s Financials At the end of the quarter, NTR had cash and cash equivalents of $895 million, up around 80.4% year over year. Long-term debt was $10,908 million, up nearly 22.4% year over year. NTR’s Guidance The company has reiterated its 2025 guidance. Retail adjusted EBITDA is expected to range from $1.65 billion to $1.85 billion. Sales volumes are expected to be in the bands of 13.6-14.4 million tons of potash, 10.7-11.2 million tons of nitrogen and 2.35-2.55 million tons of phosphate. Depreciation and amortization are expected to total between $2.35 billion and $2.45 billion, with finance costs projected to range from $0.65 billion to $0.75 billion. The effective tax rate on adjusted net earnings is expected to range between 22% and 25%. Capital expenditures are estimated to be between $2 billion and $2.1 billion. Story Continues NTR’s Price Performance Nutrien’s shares have lost 1.4% in the past year against a 7.5% rise of the industry.Zacks Investment Research Image Source: Zacks Investment Research NTR’s Zacks Rank & Key Picks NTR currently carries a Zacks Rank #3 (Hold). Better-ranked stocks worth a look in the basic materials space include Hawkins, Inc. HWKN, Contango Ore, Inc. CTGO and CSW Industrials, Inc. CSWI, each carrying a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Hawkins is scheduled to report fiscal fourth-quarter results on May 14. The consensus estimate for Hawkins’ earnings is pegged at 74 cents. HWKN beat the consensus estimate in one of the last four quarters while missing thrice, with the average earnings surprise being 6.1%. Contango Ore is slated to release first-quarter results on May 14. CTGO has a trailing four-quarter earnings surprise of 213.7%, on average. CSW Industrials is slated to release fiscal fourth-quarter results on May 22. The consensus estimate for CSWI’s fourth-quarter earnings is pegged at $2.23. CSWI has a trailing four-quarter earnings surprise of 10.1%, on average. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CSW Industrials, Inc. (CSWI):Free Stock Analysis Report Hawkins, Inc. (HWKN):Free Stock Analysis Report Nutrien Ltd. (NTR):Free Stock Analysis Report Contango ORE, Inc. (CTGO):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Nutrien's Earnings and Revenues Lag Estimates in Q1, Down Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...